Research and Developments

Page 9 of 21« First...7891011...20...Last »

November 6, 2014

Study May Lead to More Accurate Long-Term Prediction of Wet AMD

Posted in: Latest News, Research and Developments

Stanford University School of Medicine scientists have found a new way to forecast which patients with age-related macular degeneration (AMD) are likely to progress to the advanced wet form of the disease. Until now, there has been no effective way to to do this. The new method predicts whether a patient’s vision would, if untreated, probably
read more »

October 31, 2014

Stem Cells Might Now Replace Photoreceptors

Posted in: Latest News, Research and Developments

The media has been full of news about sight restoration from stem cells. In trials, stem cells are healing the retinal layer (retinal pigment epithelium) that supports the nerve cells (photoreceptors) responsible for seeing light. Scientists, however, have not yet been able to replace damaged photoreceptor cells in humans, but a recent study offers hope
read more »

October 22, 2014

“Hubble Lens” May Be Next IOL For AMD

Posted in: Latest News, Research and Developments

by Dan Roberts London Eye Hospital Pharma announced today that it has initiated U.S. discussions to gain clinical data for its iolAMD lens system.  iolAMD is a novel intraocular lens (IOL) system designed to restore lost vision and provide an independent lifestyle for patients with dry AMD and related diseases. The technology behind the iolAMD lens
read more »

October 16, 2014

Study Shows No Difference Between Tinted and Clear IOLS

Posted in: Latest News, Research and Developments

by Dan Roberts For several years, eye doctors have been debating the value of tinted intraocular lenses (IOLs) in eyes that have undergone cataract surgery. Those in favor of them argue that they reduce the retina’s exposure to potentially hazardous ultraviolet and blue light. The main argument against them is that they cause a decrease
read more »

October 15, 2014

Stem Cell Trial Yields Surprising Results

Posted in: Latest News, Research and Developments

by Dan Roberts Advanced Cell Technology, Inc. (now owned by Astellas) has been conducting promising safety trials for stem cell treatment of macular degeneration, but a six-month follow up has yielded even better news than expected. ACT announced that Phase 1/2 clinical data treatment of Stargardt’s macular degeneration (SMD) and dry age-related macular degeneration (AMD). Surprising even
read more »

September 23, 2014

Gene Profiling Technique Accelerates Stem Cell Therapies for Retinal Diseases

Posted in: Latest News, Research and Developments

(Source: National Eye Institute, National Institutes of Health) Researchers at the National Institutes of Health have developed a technique that will streamline the production of stem-cell derived tissues. The technique will help the researchers in their efforts to use patients’ skin cells to create new retinal tissue, a therapy that has been recently applied to
read more »

June 24, 2014

New research on UV rays and cataract

Posted in: Latest News, Research and Developments

Courtesy: National Eye Institute, National Institutes of Health (NEI/NIH) A new study offers an explanation for how years of chronic sunlight exposure can increase the risk of cataract, a clouding of the eye lens that typically occurs with aging. The study firms up a link between the sun’s damaging rays and a process called oxidative
read more »

June 24, 2014

Squalamine Eye Drops Under Study for Wet AMD

Posted in: Latest News, Research and Developments

(Updated 4/17/16) On June 24, 2014, Ohr Pharmaceutical, Inc. announced positive top-line interim results for its Phase 2 clinical trial of Squalamine eye drops in patients with wet age-related macular degeneration (wet AMD). The data demonstrated a positive benefit in multiple visual function including a gain in visual acuity of +10.4 letters with Squalamine eye
read more »

June 17, 2014

Omega-3 Inhibits Retinal Blood Vessel Growth

Posted in: Latest News, Research and Developments

Researchers from Massachusetts Eye and Ear/Schepens Eye Research Institute, Harvard Medical School and other institutions have demonstrated for the first time that the omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), DHA and EPA, can inhibit choroidal neovascularization (CNV). Their findings will be published in PNAS Online Early Edition the week of June 16-20, 2014. “These are
read more »

June 12, 2014

Stem Cell Trial for Myopic Macular Degeneration

Posted in: Latest News, Research and Developments

Advanced Cell Technology (ACT) announced in a shareholders’ conference call on June 9, 2014, that it has initiated its myopic macular degeneration (MMD) trial at Jules Stein Eye Institute at UCLA. The open-label study will enroll 12 patients, with cohorts of 3 patients each in an ascending dosage format. As with it’s current trials for
read more »

Page 9 of 21« First...7891011...20...Last »

Custom Wordpress design and web development by Jeff Roberts Web Design

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann